Multiple Assemblies exist for SMTL entry 6ten
Crystal structure of Dot1L in complex with an inhibitor (compound 11).; X-RAY DIFFRACTION 2.21 Å

	SMTL ID 6ten.1 Ligands 3-[(4-azanyl-6-methoxy-1,3,5-triazin-2-yl)amino]-4-[[(~{S})-[2,2-bis(fluoranyl)-1,3-benzodioxol-4-yl]-(3-chloranylpyridin-2-yl)methyl]amino]benzenesulfonamide; SULFATE ION Polypeptides Histone-lysine N-methyltransferase, H3 lysine-79 specific Oligo-state monomer
	SMTL ID 6ten.2 Ligands 3-[(4-azanyl-6-methoxy-1,3,5-triazin-2-yl)amino]-4-[[(~{S})-[2,2-bis(fluoranyl)-1,3-benzodioxol-4-yl]-(3-chloranylpyridin-2-yl)methyl]amino]benzenesulfonamide; SULFATE ION Polypeptides Histone-lysine N-methyltransferase, H3 lysine-79 specific Oligo-state monomer